Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study.

Ruilin XiongZhuoting ZhuYu JiangXiangbin KongJian ZhangMingguang HeKaterina KiburgYixiong YuanYanping ChenShiran ZhangMeng XuanJunwen ZengIan G MorganMingguang He

Published in: Clinical & experimental ophthalmology (2022)

Continued RLRL therapy sustained promising efficacy and safety in slowing myopia progression over 2 years. A modest rebound effect was noted after treatment cessation.

Keyphrases

study protocol
randomized controlled trial
stem cells
phase iii
bone marrow
open label
replacement therapy
optical coherence tomography